Review of malaria risk and prevention for use in corporate travel.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18695454.
- Also identified by DOI 10.1097/JOM.0b013e3181808068.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Malaria continues to be a significant, life-threatening illness in many parts of the world. For corporate travelers from countries with low endemicity, the risk of infection is considerable. Many corporate travelers are unaware of their risk, unsure of the correct preventative measures, and receive incorrect advice regarding prevention or do not comply with advice they have received. This review addresses the risk of malaria to the nonimmune corporate traveler, disease transmission, and recommended means of prevention, including prevention of mosquito bites and antimalaria chemoprophylaxis.
Medical subject headings
- Antimanic Agents
- Malaria
- Travel